期刊文献+

IGF-1R基因多态性与原发性肝癌易感性的相关性研究

Correlation between IGF-1R polymorphism and genetic susceptibility to hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨广西肝癌高发区肝癌相关基因IGF-1R基因多态性与原发性肝癌易感性的关系。方法采用病例对照研究方法,在广西肝癌高发现场人群中选取113例原发性肝癌及113名健康对照人群。以筛选IGF-1R基因SNPrs61740868位点为遗传标志,采用聚合酶链式反应-限制性片段长度多态性方法(PCR-RFLP法)检测IGF-1R基因rs61740868多态性及其基因分布的频率。结果肝癌病例组与对照组IGF-1R基因rs61740868位点均未发生基因突变,其基因型均为CC型,两组比较差异无统计学意义(P>0.05)。结论 IGF-1R基因rs61740868位点多态性与肝癌发生无关,可能不是肝癌的危险因素之一。 Objective To explore the correlation between IGF-1R polymorphism and genetic susceptibility to hepatocellular carcinoma (HCC) in the area with high incidence of HCC in Guangxi. Methods A case-control study was conducted which in- cluded 113 HCC patients and 113 normal controls. All of the cases were from the areas with high incidence of HCC in Guangxi. The SNP locus rs 61740868 of gene IGF-1R was selected as a genetic marker,and its genotypes as well as mutation frequency were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results There was no mutation in SNP locus rs 61740868 of IGF-1R in both HCC cases and controls. The expressions of IGF-1R were not statistically different between the two groups (P 〉 0. 05). Conclusion Polymorphism of IGF-1R SNP locus rs 61740868 is not associated with HCC,it may not be a risk factor for HCC.
出处 《中国癌症防治杂志》 CAS 2011年第4期277-280,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 国家自然科学基金项目(30960333) 广西自然科学基金资助项目(桂科自0991017Z)
关键词 原发性肝癌 IGF-1 R基因 单核苷酸多态性 Hepatocellular carcinoma Insulin.-like growth factor 1 receptor ( IGF-1 R) Single nucleotide polymorphism
  • 相关文献

参考文献11

  • 1黄天壬,余家华,张振权,石建基,刘锦玲,何振芳,黄昭东,徐庆芬.广西肝癌流行特征和流行趋势分析[J].广西医学,2000,22(4):677-679. 被引量:23
  • 2Hopfner M, Huether A,Sutter AP, et al. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells [J]. Biochem Pharmacol,2006,71 (10) : 1435-1448.
  • 3Qin H, Liu B, Shi T, et al. Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis [ J ]. J Int Med Res, 2010,38 ( 3 ) : 760-768.
  • 4Lin ZH,Xin YN,Dong QJ,et al. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis [ J]. BMG Gastroenterol,2010,10 : 145.
  • 5de-Alencar SA, Lopes JC. A comprehensive in silico analysis of the functional and structural impact of SNPs in the IGF1R gene [J]. J Biomed Biotechnol, 2010,2010 : 715139.
  • 6MacDonald K,Porter GA,Guemsey DL,et al. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma [J]. Cancer Epidemiol,2009,33(1) : 37.40.
  • 7Chen C, Freeman R,Voigt LF,et al. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I,insulin-like growth factor binding protein-3, and insulin-like growth factor-1 receptor [ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15 ( 12 ) : 2461-2466.
  • 8Dang X, Javle M, Hess KR, et al. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer [ J]. Gastroenterology ,2010,139(2) :464-473.
  • 9Lonn S, Rothman N, Shapiro WR, et al. Genetic variation in insulin-like growth factors and brain tumor risk [J]. Ncuro Oncol,2008,10(4) : 553-559.
  • 10Winder T, Zhang W, Yang D.et al. Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients [J]. Clin Cancer Res,2010,16(22) : 5591-5602.

二级参考文献4

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部